Skip to main content

Alpha Cash Expands Its National Footprint: Extends Free Check Deposits for Millions of Households Through September 30, 2026

With check deposit capabilities now reaching across much of the U.S., Alpha Cash is positioned to serve millions of unbanked and underbanked households and is making check deposits free for every user through Sept. 30, 2026 CORNELIUS, N.C., July 06, 2026 (GLOBE NEWSWIRE) — Alpha Modus Holdings, Inc. (NASDAQ: AMOD), through its wholly owned subsidiary Alpha Modus Financial Services, LLC, announced today that check deposit is now available in 38 states, significantly extending the reach of its mobile financial services platform, Alpha Cash, toward the tens of millions of American households that live outside the traditional banking system.To mark the expansion, the Company is making check deposits free for every Alpha Cash user through Sept. 30, 2026. The Alpha Cash app is available for iOS on the Apple Store and for Android on...

Continue reading

North American Financial 15 Split Corp Completes Preferred Share Offering of $102,460,000

TORONTO, July 06, 2026 (GLOBE NEWSWIRE) — North American Financial 15 Split Corp. (the “Company”) is pleased to announce that it has completed the overnight offering of Preferred shares (TSX: FFN.PR.A) of the Company. Total gross proceeds of the offering were $102.5 million. The Preferred shares will begin trading on the Toronto Stock Exchange under the existing symbol of FFN.PR.A. The offering was led by National Bank Financial Inc.   The net proceeds of the offering will be used by the Company to invest in an actively managed, high quality portfolio primarily consisting of financial services companies made up of Canadian and U.S. issuers as follows: Bank of Montreal, The Bank of Nova Scotia, Canadian Imperial Bank of Commerce, Royal Bank of Canada, Toronto-Dominion Bank, National Bank of Canada, Manulife Financial Corporation,...

Continue reading

Belite Bio to Participate in the Piper Sandler Virtual Ophthalmology Investor Symposium

SAN DIEGO, July 06, 2026 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the Company will participate in a fireside chat at the Piper Sandler Virtual Ophthalmology Investor Symposium on Thursday, July 9, 2026, at 12:30 pm ET. Webcast Link InstructionsA webcast of the presentation can be accessed under “Events” in the investor relations section of the Belite Bio website at: https://investors.belitebio.com/presentations-events/events. The replay will be archived for 90 days following the presentation date. About Belite BioBelite Bio is a clinical-stage drug development company focused on advancing novel...

Continue reading

Tianrong Internet Products and Services Inc. (OTC: TIPS) Ignites Next-Gen Gaming with Launch of AI-Powered DEPIN Studios — Introducing “Depin Dash” and Revolutionary Low-Cost Game Development Platform

Breakthrough AI Gaming Studio Delivers Instant, No-Download, High-Performance Browser Games Powered by a Global Decentralized GPU Network MOUNTAINHOME, Pa., July 06, 2026 (GLOBE NEWSWIRE) — Tianrong Internet Products and Services Inc. (OTC: TIPS) (“TIPS,” “the Company,” or “Tianrong”), a leader in blockchain infrastructure, decentralized compute, and AI innovation, today announced a major strategic expansion of its wholly owned division DEPINfer.xyz with the launch of DEPIN Studios — a cutting-edge AI-powered game design and development engine poised to disrupt the $200+ billion global gaming industry. This bold move transforms DEPINfer from a decentralized compute platform into a full-scale, revenue-generating gaming ecosystem, delivering studio-quality, instantly playable games directly in the browser — no downloads, no installs,...

Continue reading

GuideAI Health Appoints Renowned Interventional Radiologist Dr. James Benenati to Advisory Board Following FDA 510(k) Clearance of VAOT

Leading Vascular Specialist and Penumbra Chief Medical Officer Joins GuideAI to Help Advance Its Recently FDA-Cleared VAOT Triage Software BOSTON, July 06, 2026 (GLOBE NEWSWIRE) — GuideAI Health Corp. (Cboe CA: GDAI) (“GuideAI” or the “Company“) recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for VascularAssist Occlusion Triage (VAOT) (please see news release dated June 22nd, 2026), the Company’s artificial intelligence software designed to support the prioritization and triage of vascular occlusion in the lower extremities. Building on this milestone, the Company is pleased to announce the appointment of James F. Benenati, MD, FSIR, a board-certified interventional radiologist and recognized leader in vascular medicine, to its Advisory Board. Dr. Benenati brings more...

Continue reading

Diginex Announces Funding Progress and Final Extension of Long-Stop Date for Proposed Acquisition of Resulticks

LONDON, July 06, 2026 (GLOBE NEWSWIRE) — Diginex Limited (NASDAQ: DGNX) (“Diginex” or the “Company”), a provider of ESG, sustainability, and compliance solutions to institutional and corporate clients, today announced that it has mutually agreed with Resulticks Global Companies Pte. Limited (“Resulticks”) a final extension of the Long Stop Date under the Sale and Purchase Agreement (the “SPA”) relating to Diginex’s proposed acquisition of Resulticks (the “Transaction”) from 30 June 2026 to 31 July 2026. The Parties believe that they have now received firm intent to fund the transaction from private investors, and are now working to finalise funding documentation. The Company reiterates that it does not intend to launch public funding rounds in order to complete the Transaction. It is anticipated...

Continue reading

Prestige Consumer Healthcare Inc. Completes Acquisition of LaCorium Health, Prices $400 Million Senior Notes Offering, and Announces First Quarter Fiscal 2027 Earnings Results Date

TARRYTOWN, N.Y., July 06, 2026 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc. (NYSE:PBH) (“Prestige”) today announced that it has closed the previously announced acquisition of LaCorium Health (“LaCorium”), priced a private offering of $400 million in senior notes, and will report its first quarter fiscal 2027 results on August 6, 2026. Completion of LaCorium Health Acquisition The Company completed the acquisition on July 1, 2026. The closing was finalized pursuant to the terms of the definitive agreement announced on May 13, 2026, under which Prestige agreed to acquire LaCorium for approximately $150 million in cash. The Company financed the transaction with cash on hand and existing credit facilities. Founded in Australia and introduced in 1998, LaCorium is a leader in Australian therapeutic skin care designed to treat...

Continue reading

Canada Diagnostic Centres, a Novacap Portfolio Company, Announces Acquisition of Shift Imaging

CALGARY, Alberta, July 06, 2026 (GLOBE NEWSWIRE) — Canada Diagnostic Centres (“CDC”), a Novacap portfolio company and a leading Canadian community-based diagnostic imaging provider, today announced the acquisition of Shift Imaging, a medical imaging clinic based in Grande Prairie, Alberta. Founded in 2020, Shift Imaging provides diagnostic imaging and related healthcare services to patients across Alberta’s Peace Region. The acquisition establishes CDC’s presence in the Peace Region, expanding its geographic footprint in Northern Alberta and enhancing access to diagnostic imaging services for patients and referring healthcare professionals. With the addition of Shift Imaging, CDC now operates 50 clinics across four provinces/regions, supported by more than 800 healthcare professionals, including over 100...

Continue reading

Antelope Enterprise Reports First Half FY 2026 Financial Results

NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) — Antelope Enterprise Holdings Limited (NASDAQ Capital Market: AEHL) (“Antelope Enterprise”, “AEHL” or the “Company”), which provides livestreaming ecommerce services, business management and information systems consulting services in China, today reported its semi-annual financial results for the six-months ended March 31, 2026. Ms. Tingting Zhang, CEO of AEHL, commented, “AEHL’s semi-annual report for fiscal 2026 shows that our loss before taxation narrowed year-over-year, from $3.8 million to $2.6 million, representing a shrinkage of $1.2 million, or 31.6%, attributed to an improvement in overall gross margin percentages and an increase in other income. Against the background of the accelerated evolution of the crypto economy, we also venture into the cryptocurrency sector and...

Continue reading

QTREX Announces Operational AME System at U.S. Government Lab with a Quantum Computing Program focused on National Security

Nes Ziona, Israel, July 06, 2026 (GLOBE NEWSWIRE) — QTREX Quantum Ltd. (Nasdaq: QTEX) (“QTREX” or the “Company”) a company focused on advancing Additively Manufactured Electronics (“AME”) for quantum computing infrastructure today announced that a U.S. Government lab conducting quantum computing programs is actively operating the Company’s AME system. The operational use places the Company’s technology inside a U.S. federal quantum and advanced-microelectronics development environment, providing the lab with direct access to the unique capabilities enabled by the Company’s AME platform. The lab is one of the most prominent U.S. government research environments focused on national security, applying advanced science and engineering to help identify, deter, defeat and mitigate threats to the United States...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.